Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention

Background: Preterm birth (PTB) is a pressing maternal and child health issue with long-standing racial inequities in outcomes and care provision. 17-Alpha-hydroxyprogesterone caproate (17OHPC) has been one of few clinical interventions for recurrent PTB prevention. Little is known about the factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Stephanie M., Kellom, Katherine S., Boelig, Rupsa C., Wang, Xi, Matone, Meredith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317597/
https://www.ncbi.nlm.nih.gov/pubmed/34327511
http://dx.doi.org/10.1089/whr.2021.0022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317597/
https://www.ncbi.nlm.nih.gov/pubmed/34327511
http://dx.doi.org/10.1089/whr.2021.0022

Ejemplares similares